Transcription of Genetic Testing – Medicare Advantage Coverage Summary
{{id}} {{{paragraph}}}
Example: biology
Genetic Testing – Medicare Advantage Coverage Summary
Page 1 of 23 UHC MA Coverage Summary : Genetic Testing Proprietary Information of UnitedHealthcare. Copyright 2020 United HealthCare Services, Inc. Coverage Summary Genetic Testing Policy Number: G-003 Products: UnitedHealthcare Medicare Advantage Plans Original Approval Date: 02/14/2008 Approved by: UnitedHealthcare Medicare Benefit Interpretation Committee Last Review Date: 08/18/2020 Related Medicare Advantage Policy Guidelines: BRCA1 and BRCA2 Genetic Testing Cytogenic Studies ( ) Genetic Testing for Lynch Syndrome Molecular Pathology Procedures for Human Leukocyte antigen (HLA) Typing Molecular Pathology/ Genetic Testing Reported with Unlisted Codes Molecular Pathology/Molecular Diagnostics/ Genetic Testing Tier 2 Molecular Pathology Procedures This information is being distributed to you for personal reference. The information belongs to UnitedHealthcare and unauthorized copying, use, and distribution are prohibited. This information is intended to serve only as a general reference resource and is not intended to address every aspect of a clinical situation.
Tumor Markers Tumor markers are covered when criteria are met; refer to the following NCDs: Tumor Antigen by Immunoassay – CA 125 (190.28) Tumor Antigen by Immunoassay – CA 19-9 (190.30) Tumor Antigen by Immunoassay – CA 15-3/CA 27.29 (190.29) Carcinoembryonic Antigen (190.26) Prostate Specific Antigen (190.31)
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: